Phase 1/2 study of mobocertinib in EGFR exon 20 insertion (ex20ins)+ metastatic NSCLC (mNSCLC): Updated results from platinum-pretreated patients (PPP)
Mobocertinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 1/2 study of mobocertinib in EGFR exon 20 insertion (ex20ins)+ metastatic NSCLC (mNSCLC): Updated results from platinum-pretreated patients (PPP) ### Output: Mobocertinib